For laboratory research use only/Not for human or animal consumption
← Catalog

PRL-8-53For research use only. Not for human consumption.

methyl 3-[2-[benzyl(methyl)amino]ethyl]benzoate
CAS 51352-88-6 · 30 × 5 mg · 150 mg total

30 × 5mg PRL-8-53. Research use only.

$29.99 USD $1.00 per unit
Researchers also ordered TAK-653 $39.99 USD

Research use only · Not for human or animal consumption

Batch and analysis

CAS
51352-88-6
Systematic name
methyl 3-[2-[benzyl(methyl)amino]ethyl]benzoate
Presentation
30 × 5 mg · 150 mg total

About this compound

For In Vitro Research Use Only – Not for Human or Veterinary Application

PRL-8-53: the whole record

Few compounds this widely discussed have less published about them. The complete record for PRL-8-53 is two documents, both from its inventor, Nikolaus R. Hansl:

  1. US patent 3,870,715 (filed 1973, granted 1975), "Substituted amino ethyl meta benzoic acid esters". It describes rat maze and shock-avoidance tests, isolated-ileum spasmolytic tests, and rodent toxicology for the compound series. It calls them "cholinergic and spasmolytic agents".
  2. One 1978 paper in Psychopharmacology (Hansl & Mead), a small double-blind study.

A PubMed search for PRL-8-53 returns that one paper. We found no independent replication, no receptor-binding study and no later research.

What it is

Methyl 3-[2-[benzyl(methyl)amino]ethyl]benzoate, a small benzoate ester with a benzylmethylamino-ethyl side chain.

Hydrochloride Free base
Formula C18H22ClNO2 C18H21NO2
MW 319.8 g/mol 283.4 g/mol
CAS 51352-87-5 51352-88-6
PubChem CID 70700868 39989

Mechanism

Unknown. The patent's "cholinergic" label rests on a gut-muscle (ileum) assay. Mechanisms you may see elsewhere, such as dopamine or serotonin effects, have no primary source.

What we sell

30 capsules of 5 mg per bottle (size 1 HPMC capsules with microcrystalline cellulose). No certificate of analysis is posted for PRL-8-53 yet, so this page quotes no purity figure and doesn't say which salt form the lot is.

Sources

Disclaimer
This compound has not been evaluated by the FDA. It is not intended to diagnose, treat, cure, or prevent any disease. All use must follow institutional and regulatory guidelines.

Terms of Sale
By purchasing, the buyer affirms they are a qualified researcher or institution. All sales are final. The purchaser assumes full responsibility for handling, use, and regulatory compliance. PRL-8-53 reference material is supplied for qualified in vitro laboratory research only — not for human or veterinary consumption, administration, compounding, dispensing, diagnostic use, therapeutic use, or patient use.

pcs v1 prlPRL-8-53
$29.99 USD